CHST12 anticorps (N-Term)

N° du produit ABIN6243813

L’anticorps anti-CHST12 Polyclonal Lapin est utilisé pour la détection de CHST12 dans des échantillons de Humain. Il a été validé pour WB et IHC (p).

Aperçu rapide pour CHST12 anticorps (N-Term) (ABIN6243813)

Antigène: CHST12 (Carbohydrate (Chondroitin 4) Sulfotransferase 12 (CHST12))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp CHST12 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: RB51728

Détail du produit anti-CHST12 anticorps

Épitope: AA 72-106, N-Term

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This CHST12 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 72-106 amino acids from the N-terminal region of human CHST12.

Isotype: Ig Fraction

Information d'application

Indications d'application: WB: 1:1000. WB: 1:2000. IHC-P: 1:25

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Date de péremption: 6 months

Détails sur CHST12

Antigène: CHST12 (Carbohydrate (Chondroitin 4) Sulfotransferase 12 (CHST12))

Autre désignation: CHST12

Sujet: Catalyzes the transfer of sulfate to position 4 of the N-acetylgalactosamine (GalNAc) residue of chondroitin and desulfated dermatan sulfate. Chondroitin sulfate constitutes the predominant proteoglycan present in cartilage and is distributed on the surfaces of many cells and extracellular matrices. Activity toward partially desulfated dermatan sulfate is however lower. Does not form 4, 6-di-O-sulfated GalNAc when chondroitin sulfate C is used as an acceptor.

Poids moléculaire: 48414

UniProt: Q9NRB3

Pathways: Glycosaminoglycan Metabolic Process